Who Buys Carboplatin from India — 829 Importers Behind a $70.9M Market
India's carboplatin import market is served by 829 active buyers who collectively imported $70.9M across 3,637 shipments. FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with a 22.4% market share, followed by EUGIA US LLC and EUGIA US LLC,. The top 5 buyers together control 38.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Carboplatin Importers — Ranked by Import Value
FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) is the leading carboplatin importer from India, holding a 22.4% share of the $70.9M market across 3,637 shipments from 829 buyers. The top 5 buyers — FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), EUGIA US LLC (UNITED STATES), EUGIA US LLC, (UNITED STATES), CHRIS LESSLY (UNITED STATES), CPC "BIOCON" LLC (UKRAINE) — collectively control 38.2% of total import value.
Top Carboplatin Buyers & Importers
Ranked by import value · 829 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI DEUTSCHLAND GMBHGERMANY KEMOCARB BP INJ. 450MG/45MKEMOCARB BP INJ. 450MG/45ML VIALCARBOPLATIN FRESENIUS KABI INJ. 450MG/45 | $15.9M | 5 | 22.4% |
| 2 | EUGIA US LLCUNITED STATES CARBOPLATIN INJECTION 600MG/60MLCARBOPLATIN INJECTION 450MG/45MLCARBOPLATIN INJECTION 10 MG/ML - US )NOS | $3.4M | 5 | 4.8% |
| 3 | EUGIA US LLC,UNITED STATES CARBOPLATIN INJECTION 600MG/60MLCARBOPLATIN INJECTION 450MG/45MLCARBOPLATIN INJECTION 10 MG/ML - US )NOS | $3.3M | 5 | 4.6% |
| 4 | CHRIS LESSLYUNITED STATES CARBOPLATIN INJECTION 600MG/60MLCARBOPLATIN INJECTION 450MG/45MLCARBOPLATIN INJECTION 10 MG/ML - US )NOS | $2.5M | 5 | 3.5% |
| 5 | CPC "BIOCON" LLCUKRAINE | $2.1M | 5 | 2.9% |
| 6 | XXI LXXS LXXUNITED STATES CARBOPLATIN INJECTION 600MG/60MLCARBOPLATIN INJECTION 450MG/45MLCARBOPLATIN INJECTION 10 MG/ML - US )NOS | $1.3M | 5 | 1.8% |
| 7 | FRESENIUS KABI (THAILAND) LTDTHAILAND KEMOCARB BP INJ. 450MG/45MKEMOCARB BP INJ. 450MG/45ML VIALCARBOPLATIN FRESENIUS KABI INJ. 450MG/45 | $1.1M | 5 | 1.6% |
| 8 | FRESENIUS KABI COLOMBIA SASCOLOMBIA KEMOCARB BP INJ. 450MG/45MKEMOCARB BP INJ. 450MG/45ML VIALCARBOPLATIN FRESENIUS KABI INJ. 450MG/45 | $1.1M | 5 | 1.5% |
| 9 | THE ESSES PHARMACY (PVT) LTDSRI LANKA CARBOPLATIN INJECTION 600MG/60MLCARBOPLATIN INJECTION 450MG/45MLCARBOPLATIN 450 INJ | $1.1M | 5 | 1.5% |
| 10 | ACCORD FARMA S A DE C VMEXICO NAPROPLAT 450MG/45ML CARBOPLATIN INJECTKEMOCARB INJ. BP 450MG/45ML, | $898.5K | 5 | 1.3% |
| 11 | CPC BIOCON LLCUKRAINE | $817.5K | 5 | 1.2% |
| 12 | MULTICARE PHARMACEUTICALS PHILIPPINPHILIPPINES NAPROPLAT 450MG/45ML CARBOPLATIN INJECTKEMOCARB INJ. BP 450MG/45ML, | $786.8K | 5 | 1.1% |
| 13 | ACCORD HEALTHCARE INCCANADA NAPROPLAT 450MG/45ML CARBOPLATIN INJECTKEMOCARB INJ. BP 450MG/45ML, | $755.5K | 5 | 1.1% |
| 14 | FRESENIUS KABI MALAYSIA SDN BHDMALAYSIA KEMOCARB BP INJ. 450MG/45MKEMOCARB BP INJ. 450MG/45ML VIALCARBOPLATIN FRESENIUS KABI INJ. 450MG/45 | $730.1K | 5 | 1.0% |
| 15 | FRESENIUS KABI (THAILAND) LTD.,THAILAND KEMOCARB BP INJ. 450MG/45MKEMOCARB BP INJ. 450MG/45ML VIALCARBOPLATIN FRESENIUS KABI INJ. 450MG/45 | $701.9K | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Carboplatin — and from which countries?
Flow of Carboplatin exports from India: each country's share and the named importers behind the numbers
Carboplatin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany emerges as the first largest importing country, achieving a total trade value of $16.0M through 391 shipments. This represents a market share of 22.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• FRESENIUS KABI DEUTSCHLAND GMBH - $15.9M (99.3% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $40.9K, indicating premium pricing strategy compared to the market average of $19.5K.
Germany is a key market for Carboplatin imports, representing 22.6% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $12.2M through 65 shipments. This represents a market share of 17.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EUGIA US LLC - $3.4M (27.8% of country's total business)
• EUGIA US LLC, - $3.3M (27.0% of country's total business)
• CHRIS LESSLY - $2.5M (20.3% of country's total business)
• XXI LXXS LXX - $1.3M (10.6% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $187.0K, indicating premium pricing strategy compared to the market average of $19.5K.
United States is a key market for Carboplatin imports, representing 17.1% of total trade value.
3Thailand
Thailand emerges as the third largest importing country, achieving a total trade value of $4.8M through 24 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• FRESENIUS KABI (THAILAND) LTD - $1.1M (23.6% of country's total business)
• FRESENIUS KABI (THAILAND) LTD., - $701.9K (14.7% of country's total business)
• FRESENIUS KABI THAILAND LTD - $651.7K (13.6% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $199.5K, indicating premium pricing strategy compared to the market average of $19.5K.
Thailand is a key market for Carboplatin imports, representing 6.8% of total trade value.
4Philippines
Philippines emerges as the fourth largest importing country, achieving a total trade value of $3.2M through 16 shipments. This represents a market share of 4.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• MULTICARE PHARMACEUTICALS PHILIPPIN - $786.8K (24.3% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $202.7K, indicating premium pricing strategy compared to the market average of $19.5K.
Philippines is a key market for Carboplatin imports, representing 4.6% of total trade value.
5Ukraine
Ukraine emerges as the fifth largest importing country, achieving a total trade value of $2.9M through 7 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ukraine has a diverse importer base, with their top importers including:
• CPC "BIOCON" LLC - $2.1M (70.9% of country's total business)
• CPC BIOCON LLC - $817.5K (28.1% of country's total business)
Key Insight: Ukraine demonstrates strong market positioning with an average shipment value of $415.7K, indicating premium pricing strategy compared to the market average of $19.5K.
Ukraine is a key market for Carboplatin imports, representing 4.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Carboplatin buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Carboplatin imported from India encompasses several key segments:
1. Distributors: Entities that purchase Carboplatin in bulk to supply to healthcare providers. For instance, FRESENIUS KABI DEUTSCHLAND GMBH in Germany, accounting for $15.90 million in imports, likely operates as a distributor, supplying hospitals and clinics. Distributors typically place large, periodic orders to maintain a steady supply chain.
2. Hospital Groups: Healthcare institutions procuring directly for patient treatment. While specific hospital groups are not identified in the top buyers, entities like FRESENIUS KABI COLOMBIA SAS ($1.08 million) may serve hospital networks. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, scheduled orders.
3. Retail Chains: Pharmacy chains that stock Carboplatin for outpatient prescriptions. THE ESSES PHARMACY (PVT) LTD in Sri Lanka, with imports totaling $1.06 million, exemplifies this segment. Retail chains order based on prescription trends, leading to variable order sizes and frequencies.
4. Government Procurement: National health agencies and international organizations like UNICEF and the Global Fund procure Carboplatin for public health initiatives. While not explicitly listed among the top buyers, such entities engage in tender-based purchasing, often resulting in large, infrequent orders aligned with budget cycles and program needs.
5. Re-exporters: Companies that import Carboplatin for the purpose of exporting to other markets. For example, ACCORD FARMA S A DE C V in Mexico, with imports of $0.90 million, may distribute to neighboring countries. Re-exporters' purchasing patterns depend on regional demand and trade agreements, leading to variable order sizes.
6. Contract Manufacturers: Firms that import Carboplatin as an active pharmaceutical ingredient (API) for formulation into finished products. EUGIA US LLC in the United States, with combined imports of approximately $6.66 million, likely falls into this category. Contract manufacturers place orders based on production schedules and client demands, resulting in regular, sizable purchases.
Country-Specific Import Regulations
TransData Nexus Carboplatin buyer market intelligence
1Country-Specific Import Regulations
Germany
1. Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 7 to 12 months.
4. Import Tariff/Duty: Medicinal products under HS Code 30049047 are typically exempt from import duties within the EU.
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Requires FDA approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including compliance with Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline: ANDA approvals average 10 months; NDAs may take longer.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are generally duty-free.
Thailand
1. Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
2. Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.
3. Estimated Timeline: Approximately 12 to 18 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are subject to a 5% import duty.
Philippines
1. Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving evaluation of quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 6 to 12 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are generally exempt from import duties.
Ukraine
1. Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
2. Import Registration Process: Requires state registration, including submission of a dossier with quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 12 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are typically exempt from import duties.
Demand Drivers & Market Opportunity
TransData Nexus Carboplatin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Carboplatin is primarily driven by the prevalence of cancers such as ovarian, lung, and testicular cancers, for which Carboplatin is a standard chemotherapy agent. According to the World Health Organization (WHO), cancer remains a leading cause of morbidity and mortality worldwide, with approximately 19.3 million new cases and 10 million cancer-related deaths in 2020. This high disease burden necessitates substantial procurement of effective chemotherapeutic agents like Carboplatin.
Government healthcare programs and the expansion of universal health coverage in various countries have also bolstered the demand for essential medicines. Carboplatin's inclusion in the WHO Essential Medicines List underscores its critical role in cancer treatment, prompting national health systems to prioritize its availability. Tender-based purchasing mechanisms are commonly employed by governments and international organizations to procure such essential medicines, ensuring cost-effectiveness and consistent supply. The presence of 829 buyers across 138 countries, as per TransData Nexus data, reflects a broad and sustained global demand for Carboplatin, presenting significant market opportunities for suppliers.
Common Questions — Carboplatin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest carboplatin buyer importing from India?
Based on import volume and value, FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with $15.9M in imports and a 22.4% market share — the highest of any single carboplatin importer. EUGIA US LLC (UNITED STATES) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.
QHow many companies buy carboplatin from India?
There are 829 active carboplatin buyers importing from India, with a combined market of $70.9M across 3,637 shipments to 138 countries. The top 5 buyers hold 38.2% of total import value, while the remaining 824 buyers handle the other 61.8%.
QWhich countries import the most carboplatin from India?
The top importing countries for carboplatin from India are Germany (22.6%), United States (17.1%), Thailand (6.8%), Philippines (4.6%), Ukraine (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of carboplatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for carboplatin from India?
The average import transaction value for carboplatin from India is $19.5K, with an average unit price of $16.64 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Carboplatin buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Carboplatin imported from India encompasses several key segments:
1. Distributors: Entities that purchase Carboplatin in bulk to supply to healthcare providers. For instance, FRESENIUS KABI DEUTSCHLAND GMBH in Germany, accounting for $15.90 million in imports, likely operates as a distributor, supplying hospitals and clinics. Distributors typically place large, periodic orders to maintain a steady supply chain.
2. Hospital Groups: Healthcare institutions procuring directly for patient treatment. While specific hospital groups are not identified in the top buyers, entities like FRESENIUS KABI COLOMBIA SAS ($1.08 million) may serve hospital networks. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, scheduled orders.
3. Retail Chains: Pharmacy chains that stock Carboplatin for outpatient prescriptions. THE ESSES PHARMACY (PVT) LTD in Sri Lanka, with imports totaling $1.06 million, exemplifies this segment. Retail chains order based on prescription trends, leading to variable order sizes and frequencies.
4. Government Procurement: National health agencies and international organizations like UNICEF and the Global Fund procure Carboplatin for public health initiatives. While not explicitly listed among the top buyers, such entities engage in tender-based purchasing, often resulting in large, infrequent orders aligned with budget cycles and program needs.
5. Re-exporters: Companies that import Carboplatin for the purpose of exporting to other markets. For example, ACCORD FARMA S A DE C V in Mexico, with imports of $0.90 million, may distribute to neighboring countries. Re-exporters' purchasing patterns depend on regional demand and trade agreements, leading to variable order sizes.
6. Contract Manufacturers: Firms that import Carboplatin as an active pharmaceutical ingredient (API) for formulation into finished products. EUGIA US LLC in the United States, with combined imports of approximately $6.66 million, likely falls into this category. Contract manufacturers place orders based on production schedules and client demands, resulting in regular, sizable purchases.
Country-Specific Import Regulations
TransData Nexus Carboplatin buyer market intelligence
1Country-Specific Import Regulations
Germany
1. Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 7 to 12 months.
4. Import Tariff/Duty: Medicinal products under HS Code 30049047 are typically exempt from import duties within the EU.
United States
1. Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process: Requires FDA approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including compliance with Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline: ANDA approvals average 10 months; NDAs may take longer.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are generally duty-free.
Thailand
1. Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
2. Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.
3. Estimated Timeline: Approximately 12 to 18 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are subject to a 5% import duty.
Philippines
1. Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving evaluation of quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 6 to 12 months.
4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are generally exempt from import duties.
Ukraine
1. Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
2. Import Registration Process: Requires state registration, including submission of a dossier with quality, safety, and efficacy data.
3. Estimated Timeline: Approximately 12 months.
4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are typically exempt from import duties.
Demand Drivers & Market Opportunity
TransData Nexus Carboplatin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Carboplatin is primarily driven by the prevalence of cancers such as ovarian, lung, and testicular cancers, for which Carboplatin is a standard chemotherapy agent. According to the World Health Organization (WHO), cancer remains a leading cause of morbidity and mortality worldwide, with approximately 19.3 million new cases and 10 million cancer-related deaths in 2020. This high disease burden necessitates substantial procurement of effective chemotherapeutic agents like Carboplatin.
Government healthcare programs and the expansion of universal health coverage in various countries have also bolstered the demand for essential medicines. Carboplatin's inclusion in the WHO Essential Medicines List underscores its critical role in cancer treatment, prompting national health systems to prioritize its availability. Tender-based purchasing mechanisms are commonly employed by governments and international organizations to procure such essential medicines, ensuring cost-effectiveness and consistent supply. The presence of 829 buyers across 138 countries, as per TransData Nexus data, reflects a broad and sustained global demand for Carboplatin, presenting significant market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 829 global importers of Carboplatin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,637 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 138 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,637 Verified Shipments
829 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists